Genetic testing in hereditary colorectal cancer: Indications and procedures

American Journal of Gastroenterology

Volumn 94, Issue 9, 1999, Pages 2344-2356

  Terdiman, Jonathan P ^a,b   Conrad, Peggy G ^a   Sleisenger, Marvin H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; DNA; MICROSATELLITE DNA;

ADENOMATOUS POLYP; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; COLONOSCOPY; COLORECTAL CANCER; DENATURING GRADIENT GEL ELECTROPHORESIS; FAMILIAL POLYPOSIS; GENE; GENE MUTATION; GENETIC COUNSELING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; MICROSATELLITE INSTABILITY; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0033200024     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.01356.x     Document Type: Review

References (106)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA-A Cancer J Clinicians 1997;47. 5-27.
2. SEER cancer statistics review,1973-1995. (http./Avww-seer. ims.nci.nih.gov/Publications/CSR7394/colorect.pdO. National Cancer Institute, ed., 1999.
3. Sandier RS. Epidemiology and risk factors for colorectal cancer. Gastroenterol Clin North Am 1996;25:717-35.
4. Slattery ML, Boucher KM, Caan BJ, et al. Eating patterns and risk of colon cancer. Am J Epidemiol 1998;148:4-16.
5. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
6. St. John DJB, McDermott FT, Hopper JL, et al. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993;118:785-90.
7. Slattery ML, Kerber RA. Family history of cancer and colon' cancer risk: The Utah population database. J Natl Cancer Inst 1994:86:1618-26.
8. Fuchs CS, Giovannucci EL, Colditz GA, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994;331:1669-74.
9. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996;334: 82-7.
10. Ahsan H, Neugut AI, Garbowski GC, et al. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Inter Med 1998;128:900-5.
11. Burt RW. Screening of patients with a positive family history of colorectal cancer. Gastrointest Endosc Clin North Am 1997;7:65-79.
12. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338:1481-7.
13. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997;17:79-83.
14. Lindor NM, Greene MH. The concise handbook of family cancer syndromes. Mayo Familial Cancer Program. J Natl Cancer Inst 1998;90:1039-71.
15. Spirio L, OIschwang S, Groden J, et al. Alleles of the APC gene: An attenuated form of familial polyposis. Cell 1993; 75:951-7.
16. Lynch HT, Smyrk T, McGinn T, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of RAP. Cancer 1995;76: 2427-33.
17. Church JM, McGannon E, Hull-Boiner S, et al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35:1170-3.
18. Campbell WJ, Spence RA, Parks TG. Familial adenomatous polyposis. Br J Surg 1994;81: 1722-33.
19. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998;85:742-50.
20. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-2.
21. Offitt K. Clinical cancer genetics. New York: Wiley-Liss, 1998.
22. Watanabe H, Enjoli M, Yao T, et al. Gastric lesions in familial adenomatosis coli: Their incidence and histological analysis. Hum Pathol 1978;9:269-83.
23. Zwick A, Munir M, Ryan CK, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 1997; 113:659-63.
24. Tiret A, Taiel-Sartral M, Tiret E, et al. Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol 1997;81:755-8.
25. Ruhswurm I, Zehetmayer M, Dejaco C, et al. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis. Am J Ophthalmol 1998;125:680-6.
26. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-47.
27. Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: Two genetic diseases? J Clin Oncol 1997;15: 2744-58.
28. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991;253: 661-5.
29. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
30. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359:235-7.
31. Miyoshi Y, Ando H, Nagase H, et al. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sei 1992;89:4452-6.
32. Gryfe R, Di Nicola N, Gallinger S, et al. Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res 1998:58:4040-3.
33. Polakis P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1997; 1332:F127-47.
34. O'Sullivan MJ, McCarthy TV, Doyle CT. Familial adenomatous polyposis: From bedside to benchside. Am J Clin Pathol 1998:109:521-6.
35. Giardiello FM, Brensinger JD, Luce MC, et al. Phenotypic expression of disease in families that have mutations in the 5' region of the adenomatous polyposis coli gene. Ann Intern Med 1997:126: 514-9.
36. Gardner RJ, Kool D, Edkins E, et al. The clinical correlates of a 3' truncating mutation (codons 1982-1983) in the adenomatous polyposis coli gene. Gastroenterology 1997; 113: 326-31.
37. Brensinger JD, Laken SJ, Luce MC, et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut 1998;43:548-52.
38. Olschwang S, Tiret A, Laurent-Puig P, et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993;75: 959-68.
39. Wallis YL, Macdonald F, Hultén M, et al. Genotypephenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet 1994;94:543-8.
40. Wu JS, Paul P, McGannon EA, et al. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg-1998;227:57-62.
41. Ponz de Leon M, Sassatelli R, Benatti P, et al. Identification of hereditary nonpolyposis colorectal cancer in the general population: The 6-year experience of a population-based registry. Cancer 1993;71: 3493-501.
42. Evans DG, Walsh S, Jeacock J, et al. Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer. Br J Surg 1997;84: 1281-5.
43. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87: 159-70.
44. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110: 1020-7.
45. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.
46. Lynch HT, Smyrk T. Hereditary nonpolyposisbcolorectal cancer (Lynch syndrome). An updated review. Cancer 1996; 78:1149-67.
47. Mecklin JP, Jarvinen H. Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum 1993:36:927-9.
48. Jass JR, Smyrk TC, Stewart SM, et al. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994; 14:1631-4.
49. Sankila R, Aaltonen LA, Jarvinen HJ, et al. Better survival rates in patients with MLHl-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
50. Myrhoj T, Bisgaard ML, Bernstein I, et al. Hereditary nonpolyposis colorectal cancer: Clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol 1997;32:572-6.
51. Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998;83:259-66.
52. Bertario L, Russo A, Sala P, et al. Survival of patients with hereditary colorectal cancer: Comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Intematl J Cancer 1999;80:83-7.
53. Warthin AS. The further study of a cancer family. J Cancer Res 1925;9:279-86.
54. Suspiro A, Fidalgo P, Cravo M, et al. The Muir-Torre syndrome: A rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol 1998;93: 1572-4.
55. Kruse R, Riitten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet 1998;63:63-70.
56. Vasen HFA, Mecklin JP, Meera Khan P, et al. The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer. Dis Colon Rectum 1991;34:424-5.
57. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993 ;75:1027-3 8.
58. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:215-25.
59. Bronner CE, Baker SM, Morrison PT, et al. Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer. Nature 1994; 368: 258-61.
60. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
61. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997;17:271-2.
62. Peltomäki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer, database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997:113:146-58.
63. Peltomäki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-2.
64. Parsons R, Li GM, Longley MJ, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993; 75:1227-36.
65. Aaltonen LA, Peltomäki P, Mecklin JP, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54: 1645-8.
66. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58: 524857.
67. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability, definition and correlation with mismatch repair protein expression. Cancer Res 1997;57:474956.
68. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
69. Parsons R, Myeroff LL, Liu B, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995;55: 5548-50.
70. Akiyama Y, Iwanaga R, Saitoh K, et al. Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology 1997;112: 33-9.
71. Rampino N, Yamamoto H, lonov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-9.
72. Yagi OK, Akiyama Y, Nornizu T, et al. Proapoptotic gene BAX is frequently mutated in hereditary nonpolyposis colorectal cancers but not in adenomas. Gastroenterology 1998; 114:268-74.
73. Ouyang H, Furukawa T, Abe T, et al. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. Clin Cancer Res 1998;4: 1071-4.
74. Yamamoto H, Sawai H, Weber TK, et al. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res 1998; 58: 997-1003.
75. Bocker T, Diermann J, Friedl W, et al. Microsatellite instability analysis: A multicenter study for reliability and quality control. Cancer Res 1997;57:4739-43.
76. Lin KM, Shashidharan M, Thorson AG, et al. Cumulative incidence of colorectal and extracolonic cancers in MLHland MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1988;2:67-71.
77. Lin KM, Shashidharan M, Ternent ÇA, et al. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population. Dis Colon Rectum 1998;41:428-33.
78. Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997;277:915-9.
79. Järvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
80. Syngal S, Weeks JC, Schräg D, et al. Benefits of colonoscopic surveillance and prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer mutations. Ann Intern Med 1998; 129:787-96.
81. Petrukhin L, Dangel J, Vanderveer L, et al. The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds. Cancer Res 1997; 57: 5480-4.
82. Abrahamson J, Moslehi R, Vesprini D, et al. No association of the I1307K APC allele with ovarian cancer risk in Ashkenazi Jews. Cancer Res 1998;58:2919-22.
83. Frayling IM, Beck NE, Ilyas M, et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sei USA 1998;95: 10722-7.
84. White RL. Excess risk of colon cancer associated with a polymorphism of the APC gene? Cancer Res 1998;58: 4038-9.
85. Woodage T, King SM, Wacholder S, et al. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 1998;20:62-5.
86. Rozen P, Shomrat R, Strul H, et al. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 1999;116: 54-7.
87. Wijnen J, van der Klift H, Vasen H, et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998; 20:326-8.
88. Piepoli A, Santoro R, Cristofaro G, et al. Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1996;110: 1404-9.
89. Jass JR, Cottier DS, Jeevaratnam P, et al. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 1995;346:1200-1.
90. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62.
91. Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995;9:48-55.
92. Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer risk. Am J Public Health 1995;85:1435-8.
93. Lermari C, Marshall J, Audrain J, et al. Genetic testing for colon cancer susceptibility. Anticipated reactions of patients and challenges to providers. Internatl J Cancer 1996;69: 58-61.
94. Cromwell DM, Moore RD, Brensinger JD, et al. Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis. Gastroenterology 1998;114: 893-901.
95. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997;336: 823-7.
96. Vemon SW, Gritz ER, Peterson SK, et al. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol 1997;16: 73-86.
97. Lapham EV, Kozma C, Weiss JO. Genetic discrimination, perspectives of consumers. Science 1996;274:621-4.
98. Rodriguez-Bigas MA, Vasen HF, O'Malley L, et al. Health, life, and disability insurance and hereditary nonpolyposis colorectal cancer. Am J Hum Genet 1998;62:736-7.
99. Dickens BM, Pei N, Taylor KM. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer. Can Med Assoc J 1996;154:813-8.
100. ASHG statement. Professional disclosure of familial genetic information. The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Am J Hum Genet 1998;62:474-83.
101. Geller G, Botkin JR, Green MJ, et al. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent. JAMA 1997;277:1467-74.
102. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol 1996;14:1730-6.
103. Farrington SM, Lin-Goerke J, Ling J, et al. Systematic analysis of hMSH2 and hMLHl in young colon cancer patients and controls. Am J Hum Genet 1998;63:749-59.
104. Weber TK, Conlon W, Petrelli NJ, et al. Genomic DNAbased hMSH2 and hMLHl mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res 1997:57:3798-803.
105. Percesepe A, Anti M, Roncucci L, et al. The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer. Br J Cancer 1995:72:1320-3.
106. Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998:339:511-8.